Document is current
Any future updates will be listed below
-
Authors
Capelle, Christophe M.
Ciré, Séverine https://orcid.org/0000-0001-9991-2170
Hedin, Fanny
Hansen, Maxime
Pavelka, Lukas
Grzyb, Kamil https://orcid.org/0000-0002-2416-9500
Kyriakis, Dimitrios https://orcid.org/0000-0003-1643-2310
Hunewald, Oliver https://orcid.org/0000-0001-5402-5084
Konstantinou, Maria
Revets, Dominique
Tslaf, Vera https://orcid.org/0000-0003-1510-4120
Marques, Tainá M. https://orcid.org/0000-0001-6098-2817
Gomes, Clarissa P. C. https://orcid.org/0000-0003-0269-6470
Baron, Alexandre
Domingues, Olivia
Gomez, Mario
Zeng, Ni https://orcid.org/0000-0003-2756-6074
Betsou, Fay
May, Patrick https://orcid.org/0000-0001-8698-3770
Skupin, Alexander https://orcid.org/0000-0002-8955-8304
Cosma, Antonio https://orcid.org/0000-0002-3686-8034
Balling, Rudi https://orcid.org/0000-0003-2902-5650
Krüger, Rejko
Ollert, Markus https://orcid.org/0000-0002-8055-0103
Hefeng, Feng Q. https://orcid.org/0000-0003-2657-7361
-
Funding
Funding for this research was provided by:
Fonds National de la Recherche Luxembourg (CORE/14/BM/8231540/GeDES, Tregbar/11228353, PRIPRIDDE/11012546/NEXTIMMUNE, PRIDE/10907093/CRITICS, PRIDE/14254520/i2TRON, PHD-2015-1/9989160)
Integrated BioBank of Luxembourg (CoPImmunoPD, PMC/2018/01)
- License Information
-
More Information
Article History
Received: 7 July 2022
Accepted: 31 October 2023
First Online: 20 November 2023
Competing interests
: Pending patent application on the protection of biomarkers for Parkinson’s disease (patent applicant: Luxembourg Institute of Health; inventors: F.Q.H., M.O. and R.K.; EP Patent Application No. 23203381.1 entitled “Early biomarker for Parkinson’s disease”). The remaining authors of this work declare no competing interests.
